{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:48:12Z","timestamp":1789436892205,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304365"],"award-info":[{"award-number":["82304365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Health and Health Commission","award":["20234Y0193"],"award-info":[{"award-number":["20234Y0193"]}]},{"name":"Shanghai Oriental Talent Youth Project"},{"name":"Shanghai \u2018Rising Stars of Medical Talents\u2019 Youth Development Program-Clinical Laboratory Practitioner Program","award":["2023-JY"],"award-info":[{"award-number":["2023-JY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13402-025-01096-z","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:54:22Z","timestamp":1754916862000},"page":"1553-1569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The m1A-SFRP2-NFAT\/TOX axis governs T cell exhaustion in gastric cancer"],"prefix":"10.1007","volume":"48","author":[{"given":"Yifan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"8","key":"1096_CR1","first-page":"CD004064","volume":"8","author":"AD Wagner","year":"2017","unstructured":"A.D. Wagner, N.L. Syn, M. Moehler, W. Grothe, W.P. Yong, B.C. Tai, J. Ho, S. Unverzagt, Chemotherapy for advanced gastric cancer. Cochrane Database Syst. Rev. 8(8), CD004064 (2017)","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"1096_CR2","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","volume":"11","author":"M Jiang","year":"2021","unstructured":"M. Jiang, K. Jia, L. Wang, W. Li, B. Chen, Y. Liu, H. Wang, S. Zhao, Y. He, C. Zhou, Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm. Sin B 11(10), 2983\u20132994 (2021)","journal-title":"Acta Pharm. Sin B"},{"issue":"21","key":"1096_CR3","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3748\/wjg.v30.i21.2734","volume":"30","author":"SY Yan","year":"2024","unstructured":"S.Y. Yan, J.G. Fan, Application of immune checkpoint inhibitors and microsatellite instability in gastric cancer. World J. Gastroenterol. 30(21), 2734\u20132739 (2024)","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"1096_CR4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"S.T. Kim, R. Cristescu, A.J. Bass, K.M. Kim, J.I. Odegaard, K. Kim, X.Q. Liu, X. Sher, H. Jung, M. Lee, S. Lee, S.H. Park, J.O. Park, Y.S. Park, H.Y. Lim, H. Lee, M. Choi, A. Talasaz, P.S. Kang, J. Cheng, A. Loboda, J. Lee, W.K. Kang, Comprehensive molecular characterization of clinical responses to PD-1 Inhibition in metastatic gastric cancer. Nat. Med. 24(9), 1449\u20131458 (2018)","journal-title":"Nat. Med."},{"issue":"7743","key":"1096_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"D. Han, J. Liu, C. Chen, L. Dong, Y. Liu, R. Chang, X. Huang, Y. Liu, J. Wang, U. Dougherty, M.B. Bissonnette, B. Shen, R.R. Weichselbaum, M.M. Xu, C. He, Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature. 566(7743), 270\u2013274 (2019)","journal-title":"Nature"},{"issue":"7667","key":"1096_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"H.B. Li, J. Tong, S. Zhu, P.J. Batista, E.E. Duffy, J. Zhao, W. Bailis, G. Cao, L. Kroehling, Y. Chen, G. Wang, J.P. Broughton, Y.G. Chen, Y. Kluger, M.D. Simon, H.Y. Chang, Z. Yin, R. Flavell, A. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 548(7667), 338\u2013342 (2017)","journal-title":"Nature"},{"issue":"6","key":"1096_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00262-024-03684-8","volume":"73","author":"D Yu","year":"2024","unstructured":"D. Yu, J. Yang, B. Wang, Z. Li, K. Wang, J. Li, C. Zhu, New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model. Cancer Immunol. Immunother. 73(6), 112 (2024)","journal-title":"Cancer Immunol. Immunother"},{"key":"1096_CR8","doi-asserted-by":"crossref","unstructured":"C. Wen, L. Wang, A. Piffko, D. Chen, X. Yu, K. Zawieracz, J. Bugno, K. Yang, E.Z. Naccasha, F. Ji, J. Wang, X. Huang, S.Y. Luo, L. Tan, B. Shen, C. Luo, M.E. Mcnerney, S.J. Chmura, A. Arina, S. Pitroda, C. He, H.L. Liang, Weichselbaum R R. YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production. J. Clin. Invest., 2024, 134(23)","DOI":"10.1172\/JCI181612"},{"issue":"20","key":"1096_CR9","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"L. Wang, H. Hui, K. Agrawal, Y. Kang, N. Li, R. Tang, J. Yuan, T.M. Rana, m(6) A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 39(20), e104514 (2020)","journal-title":"EMBO J."},{"key":"1096_CR10","doi-asserted-by":"crossref","unstructured":"M. Zhao, S. Shen, C. Xue, A Novel m1A-score model correlated with the immune microenvironment predicts prognosis in hepatocellular carcinoma. Front Immunol. 13, 805967 (2022)","DOI":"10.3389\/fimmu.2022.805967"},{"issue":"1","key":"1096_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s40001-023-01292-3","volume":"28","author":"L Zhou","year":"2023","unstructured":"L. Zhou, W. Zhou, Y. Li, R. Hua, m1A regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma. Eur. J. Med. Res. 28(1), 321 (2023)","journal-title":"Eur. J. Med. Res."},{"key":"1096_CR12","doi-asserted-by":"crossref","unstructured":"Y. Wu, D. Jiang, H. Zhang, F. Yin, P. Guo, X. Zhang, C. Bian, C. Chen, S. Li, Y. Yin, D. Bockler, J. Zhang, Y. Han, N1-Methyladenosine (m1A) regulation associated with the pathogenesis of abdominal aortic aneurysm through YTHDF3 modulating macrophage polarization. Front Cardiovasc Med. 9(883155) (2022)","DOI":"10.3389\/fcvm.2022.883155"},{"issue":"1","key":"1096_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-024-00304-0","volume":"16","author":"S Li","year":"2024","unstructured":"S. Li, T. Feng, Y. Liu, Q. Yang, A. Song, S. Wang, J. Xie, J. Zhang, B. Yuan, Z. Sun, m(1)A Inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC\/PD-L1 signaling. Int. J. Oral Sci. 16(1), 36 (2024)","journal-title":"Int. J. Oral Sci."},{"issue":"6","key":"1096_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"J.T. Leek, W.E. Johnson, H.S. Parker, A.E. Jaffe, J.D. Storey, The Sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 28(6), 882\u2013883 (2012)","journal-title":"Bioinformatics"},{"issue":"1","key":"1096_CR15","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/JOM.0000000000000599","volume":"58","author":"P Morfeld","year":"2016","unstructured":"P. Morfeld, Controlling the false discovery rate in many SMR analyses. J. Occup. Environ. Med. 58(1), e21\u2013e22 (2016)","journal-title":"J. Occup. Environ. Med."},{"key":"1096_CR16","doi-asserted-by":"crossref","unstructured":"R. Gaujoux, C. Seoighe, A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 11(367) (2010)","DOI":"10.1186\/1471-2105-11-367"},{"key":"1096_CR17","doi-asserted-by":"crossref","unstructured":"S. Hanzelmann, R. Castelo, J. Guinney, GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 14, 7 (2013)","DOI":"10.1186\/1471-2105-14-7"},{"key":"1096_CR18","doi-asserted-by":"crossref","unstructured":"D. Zeng, Z. Ye, R. Shen, G. Yu, J. Wu, Y. Xiong, R. Zhou, W. Qiu, N. Huang, L. Sun, X. Li, J. Bin, Y. Liao, M. Shi, W. Liao, IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 12, 687975 (2021)","DOI":"10.3389\/fimmu.2021.687975"},{"issue":"5","key":"1096_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"G. Yu, L.G. Wang, Y. Han, Q.Y. He, Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 16(5), 284\u2013287 (2012)","journal-title":"OMICS"},{"issue":"16","key":"1096_CR20","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","volume":"187","author":"LP Andrews","year":"2024","unstructured":"L.P. Andrews, S.C. Butler, J. Cui, A.R. Cillo, C. Cardello, C. Liu, E.A. Brunazzi, A. Baessler, B. Xie, S.R. Kunning, S.F. Ngiow, Y.J. Huang, S. Manne, A.H. Sharpe, G.M. Delgoffe, E.J. Wherry, J.M. Kirkwood, T.C. Bruno, C.J. Workman, Vignali D A A. LAG-3 and PD-1 synergize on CD8(+) T cells to drive T cell exhaustion and hinder autocrine IFN-gamma-dependent anti-tumor immunity. Cell. 187(16), 4355\u201372e22 (2024)","journal-title":"Cell"},{"issue":"16","key":"1096_CR21","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1016\/j.cell.2024.06.036","volume":"187","author":"AR Cillo","year":"2024","unstructured":"A.R. Cillo, C. Cardello, F. Shan, L. Karapetyan, S. Kunning, C. Sander, E. Rush, A. Karunamurthy, R.C. Massa, A. Rohatgi, C.J. Workman, J.M. Kirkwood, T.C. Bruno, Vignali D A A. Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8(+) T cells to promote antitumor immunity. Cell. 187(16), 4373\u20134388 (2024). e15","journal-title":"Cell"},{"issue":"7598","key":"1096_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature17392","volume":"532","author":"A Kaur","year":"2016","unstructured":"A. Kaur, M.R. Webster, K. Marchbank, R. Behera, A. Ndoye, C.H. 3 Kugel rd, V.M. Dang, J. Appleton, P. O\u2019connell M, P. Cheng, A.A. Valiga, R. Morissette, N.B. Mcdonnell, L. Ferrucci, A.V. Kossenkov, K. Meeth, H.Y. Tang, X. Yin, W.H. 3 Wood rd, E. Lehrmann, K.G. Becker, K.T. Flaherty, D.T. Frederick, J.A. Wargo, Z.A. Cooper, M.T. Tetzlaff, C. Hudgens, K.M. Aird, R. Zhang, X. Xu, Q. Liu, E. Bartlett, G. Karakousis, Z. Eroglu, R.S. Lo, M. Chan, A.M. Menzies, G.V. Long, D.B. Johnson, J. Sosman, B. Schilling, D. Schadendorf, D.W. Speicher, M. Bosenberg, A. Ribas, Weeraratna A T. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 532(7598), 250\u2013254 (2016)","journal-title":"Nature"},{"issue":"8","key":"1096_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","volume":"22","author":"H Seo","year":"2021","unstructured":"H. Seo, E. Gonzalez-Avalos, W. Zhang, P. Ramchandani, C. Yang, C.J. Lio, A. Rao, P.G. Hogan, BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells. Nat. Immunol. 22(8), 983\u2013995 (2021)","journal-title":"Nat. Immunol."},{"issue":"10","key":"1096_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41423-023-01075-0","volume":"20","author":"Y Fu","year":"2023","unstructured":"Y. Fu, J. Wang, C. Liu, K. Liao, X. Gao, R. Tang, B. Fan, Y. Hong, N. Xiao, C. Xiao, W.H. Liu, Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation. Cell. Mol. Immunol. 20(10), 1127\u20131139 (2023)","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"1096_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"A. Naimi, R.N. Mohammed, A. Raji, S. Chupradit, A.V. Yumashev, W. Suksatan, M.N. Shalaby, L. Thangavelu, S. Kamrava, N. Shomali, A.D. Sohrabi, A. Adili, A. Noroozi-Aghideh, E. Razeghian, Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell. Commun. Signal. 20(1), 44 (2022)","journal-title":"Cell. Commun. Signal."},{"issue":"2","key":"1096_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"D.L. Jardim, A. Goodman, De D. Melo Gagliato, R. Kurzrock, The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell. 39(2), 154\u2013173 (2021)","journal-title":"Cancer Cell."},{"key":"1096_CR27","doi-asserted-by":"crossref","unstructured":"C. Liu, R. Liu, B. Wang, J. Lian, Y. Yao, H. Sun, C. Zhang, L. Fang, X. Guan, J. Shi, S. Han, F. Zhan, S. Luo, Y. Yao, T. Zheng, Y. Zhang, Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. J. Immunother Cancer. 9(1) (2021)","DOI":"10.1136\/jitc-2020-001895"},{"key":"1096_CR28","doi-asserted-by":"crossref","unstructured":"M.J. Giacalone, The promise, progress, and challenges of in situ immunization agents in cancer immunotherapy. Prog Mol. Biol. Transl Sci. 209, 127\u201364 (2024).","DOI":"10.1016\/bs.pmbts.2024.02.004"},{"issue":"13","key":"1096_CR29","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1158\/0008-5472.CAN-23-3264","volume":"84","author":"S Yang","year":"2024","unstructured":"S. Yang, D. Zhang, Q. Sun, H. Nie, Y. Zhang, X. Wang, Y. Huang, Y. Sun, Single-Cell and Spatial transcriptome profiling identifies the transcription factor BHLHE40 as a driver of EMT in metastatic colorectal cancer. Cancer Res. 84(13), 2202\u20132217 (2024)","journal-title":"Cancer Res."},{"key":"1096_CR30","doi-asserted-by":"crossref","unstructured":"M.L. Cohen, A.N. Brumwell, T.C. Ho, K. Garakani, G. Montas, D. Leong, V.W. Ding, J.A. Golden, B.N. Trinh, D.M. Jablons, M.A. Matthay, K.D. Jones, P.J. Wolters, Y. Wei, H.A. Chapman, Le C.J. Saux, A fibroblast-dependent TGF-beta1\/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis. J. Clin. Invest. 134(18) (2024)","DOI":"10.1172\/JCI174598"},{"key":"1096_CR31","doi-asserted-by":"crossref","unstructured":"S.L. Topalian, J.M. Taube, D.M. Pardoll, Neoadjuvant checkpoint Blockade for cancer immunotherapy. Science, 2020, 367(6477)","DOI":"10.1126\/science.aax0182"},{"issue":"2","key":"1096_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamaoncol.2023.5269","volume":"10","author":"A Ghoreifi","year":"2024","unstructured":"A. Ghoreifi, U. Vaishampayan, M. Yin, S.P. Psutka, H. Djaladat, Immune checkpoint inhibitor therapy before nephrectomy for locally advanced and metastatic renal cell carcinoma: A review. JAMA Oncol. 10(2), 240\u2013248 (2024)","journal-title":"JAMA Oncol."},{"issue":"12","key":"1096_CR33","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s10147-024-02612-1","volume":"29","author":"A Yoshimura","year":"2024","unstructured":"A. Yoshimura, T. Kato, Y. Nakai, M. Tsujihata, S. Toyoda, M. Sato, K. Matsuzaki, W. Nakata, T. Takao, S. Inoguchi, Y. Okuda, G. Yamamichi, Y. Ishizuya, Y. Yamamoto, K. Hatano, A. Kawashima, S. Takada, H. Inoue, K. Nishimura, O. Miyake, K. Fujita, M. Nakayama, K. Nishimura, N. Nonomura, Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan. Int. J. Clin. Oncol. 29(12), 1916\u20131924 (2024)","journal-title":"Int. J. Clin. Oncol."},{"key":"1096_CR34","doi-asserted-by":"crossref","unstructured":"Van S.G. Ravensteijn, A.L. Amir, D.V.F. Tauriello, C.M.L. Van Herpen, M.J. Boers-Sonderen, Y.J.W. Wesseling, Van A.G. Brussel, D.M. C, Keizer, H.M.W. Verheul, Bol K F. Exploring the relation between TGF-beta pathway activity and response to checkpoint Inhibition in patients with metastatic melanoma. Clin. Exp. Immunol. 219(1) (2025)","DOI":"10.1093\/cei\/uxae108"},{"issue":"1","key":"1096_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41401-024-01373-x","volume":"46","author":"E Major","year":"2025","unstructured":"E. Major, K.H. Lin, S.C. Lee, K. Kaldi, B. Gyorffy, G.J. Tigyi, Z. Benyo, LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10. Acta Pharmacol. Sin. 46(1), 222\u2013230 (2025)","journal-title":"Acta Pharmacol. Sin"},{"issue":"1","key":"1096_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12964-023-01406-8","volume":"22","author":"S Liu","year":"2024","unstructured":"S. Liu, Z. Zhang, L. Jiang, M. Zhang, C. Zhang, L. Shen, Claudin-18.2 mediated interaction of gastric cancer cells and cancer-associated fibroblasts drives tumor progression. Cell. Commun. Signal. 22(1), 27 (2024)","journal-title":"Cell. Commun. Signal."},{"issue":"3","key":"1096_CR37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"V. Kumar, K. Ramnarayanan, R. Sundar, N. Padmanabhan, S. Srivastava, M. Koiwa, T. Yasuda, V. Koh, K.K. Huang, S.T. Tay, S.W.T. Ho, A.L.K. Tan, T. Ishimoto, G. Kim, A. Shabbir, Q. Chen, B. Zhang, S. Xu, K.P. Lam, H.Y. Lum, J. Teh, M. Yong, W.P. So, J.B.Y. Tan, Single-Cell atlas of lineage states, tumor microenvironment, and Subtype-Specific expression programs in gastric cancer. Cancer Discov. 12(3), 670\u2013691 (2022)","journal-title":"Cancer Discov"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01096-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:46:10Z","timestamp":1760525170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01096-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01096-z","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was approved by the Ethics Committee of Shanghai Tongji Hospital (K-2023-028). All participants provided written informed consent prior to sample collection, in accordance with the Declaration of Helsinki. Every human participant provided their consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}